MAPK1 and Familial prostate cancer: p38 seems to play a critical role in hypoxia-reoxygenation-induced increase in AR activity, as well as increased survival, clonogenicity, and invasiveness in prostate cancer cells [74], thus providing additional support for a role for p38 in androgen dependence acquisition.